POLE and endometrial cancer: Among these subtypes, new hotspot mutations in the exonuclease domain of POLE defined a subgroup of endometrial cancers with ultrahigh somatic mutation frequencies, high tumor infiltrated lymphocytes and favorable outcomes [5, 6].